Here are the Top health stories for the day:
Not equivalent to MBBS in India: NMC decision on course in Philippines
In a major setback for Foreign Medical Education in the Philippines, National Medical Commission (NMC) has refused to account for the two-year BS course towards the required minimum duration of a foreign medical course to be considered equivalent to the domestic MBBS course
In doing so, the apex medical regulator NMC clarified that BS and MD courses offered at Phillipines medical colleges are two different things and that since the pattern of BS course being taught prior to the MD course is very much in line with the module of the Class 11th & 12th in India hence, it may not be included in the required MBBS course duration for the countries where the duration is less than 54 months.
For more details, check out the full story on the link below:
Not Equivalent To MBBS In India: NMC Decision On Course In Philippines
NEET PG 2022: Edit window opens today
Through a recent notice, National Board of Examinations has announced that the Edit window for all applicants of NEET PG 2022 shall go live from 29.03.2022 (after 6 PM) and will continue till 07.04.2022 (till 11:55 PM).
Using robotic surgery at AIIMS-Jodhpur, doctors removed 9 tumors
Coffee drinking may cut heart disease risk, prolong survival
Drinking coffee-particularly two to three cups a day-is not only associated with a lower risk of heart disease and dangerous heart rhythms but also with living longer, according to studies being presented at the American College of Cardiology's 71st Annual Scientific Session. These trends held true for both people with and without cardiovascular disease. Researchers said the analyses—the largest to look at coffee's potential role in heart disease and death—provide reassurance that coffee isn't tied to new or worsening heart disease and may actually be heart protective.
For more details, check out the full story on the link below:
Good News For Coffee Lovers: Daily Intake Of Coffee May Benefit Heart
Tata Capital Healthcare Fund raises Rs 955 crore fund
Tata Capital Healthcare Fund II (TCHF II), sponsored by Tata Capital Limited, has announced the Final Close of its fund with Investor commitments of INR 955 Crores (~US$126 million), meeting its target AUM of INR 950 crores (excluding green- shoe). This was a follow-up to the Tata Capital Healthcare Fund I which had raised INR 411 Crore (~US$70 million) in 2012.
TCHF II has received commitments from domestic and international financial and strategic institutions including some of the global pharma, medical equipment companies, development financial institutions and large European Institutions indicating their support for the TCHF investment strategy. TCHF II also received commitment from the 'Self Reliant India (SRI)' Fund of the Government of India under the Ministry of Micro, Small and Medium Enterprises.
For more details, check out the full story on the link below:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.